Twin brothers Anthony and Sebastian Musco are live today, thanks to an amazing research discovery
It’s a very good thing that Edwards Lifesciences developed the Transcatheter Aortic Valve Replacement (TAVR) because Sebastion Paul Musco (known as Paul) and his twin brother Anthony Musco are alive today because of it.
The heart valve was developed due to American Heart Association-funded research carried out by Edwards Lifesciences. The procedure is a less invasive procedure than open-heart surgery, which allows a new valve to be inserted with the native, diseased aortic valve (see diagrams).
Paul and his brother Anthony were among 10 children born to Carmello and Lucia Musco in Providence, Rhode Island. The twins, now 92 years old, joined the U.S. Navy during World War II, with Anthony remaining to serve in both Korea and Vietnam and retiring after a distinguished career. Paul is founder and board chair of 44-year-old Gemini Industries and continues to go to work every day. Having had the valve procedure at Hoag Hospital on April 13, 2013, he lauds doctors Haskell and Raney for their expertise, having also implementing nine stints. Paul visited Edwards and met the people who designed the valve to thank them.
“It’s been a big success,” he says. “I feel like a young man and can’t wait to be 100!”
Paul says his brother had the procedure a few months ago at Walter Reed Hospital and is doing great. They are very close and Skype every night.
“Life is great!” smiles a very grateful Paul.
AHA and Edwards have teamed up to honor Paul at the 2018 AHA Heart & Stoke Ball on Saturday, October 13th. Paul is being recognized for his philanthropy and for having been affected by heart disease and treated at Hoag Hospital with the Edwards’ TAVR. Edwards’ Transcatheter Heart Valves Corporate Vice President Larry Wood is ball chair.